References
- MacLean A. B., Reid W. M. Benign and premalignant disease of the vulva. Br J Obstet Gynaecol 1995; 102: 359–63
- Kaufman R. H., Gardner H. L. The clinician‐pathologist and vulvar disease. Clin Obstet Gynecol 1974; 17: 1–14
- Lynch P. J. Lichen simplex chronicus (atopic/neurodermatitis) of the anogenital region. Dermatol Ther 2004; 17: 8–19
- Lynch P. J., Moyal‐Barrocco M., Bogliatto F., Micheletti L., Scurry J. 2006 ISSVD classification of vulvar dermatoses: Pathologic subsets and their clinical correlates. J Reprod Med 2007; 52: 3–9
- Ashcroft D. M., Dimmock P., Garside R., Stein K., Williams H. C. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: Meta‐analysis of randomised controlled trials. BMJ 2005; 330: 516. Epub 2005 Feb 24
- Hengge U. R., Ruzicka T., Schwartz R. A., Cork M. J. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006; 1: 1–15
- Oskay T., Kaya Sezer H., Genc C., Kutluay L. Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women. Int J Dermatol 2007; 46: 527–32
- Sarifakioglu E., Gumus I. I. Efficacy of topical pimecrolimus in the treatment of chronic vulvar pruritus: A prospective case series – a non‐controlled, open‐label study. J Dermatolog Treat 2006; 17: 276–8
- Gisondi P., Ellis C. N., Girolomoni G. Pimecrolimus in dermatology: Atopic dermatitis and beyond. Int J Clin Pract 2005; 59: 969–74
- Li C., Bian D., Chen W., Zhao C., Yin N., Wang Z. Focused ultrasound therapy of vulvar dystrophies: A feasibility study. Obstet Gynecol 2004; 104: 915–21
- Ayhan A., Guvendag Guven E. S., Guven S., Sakinci M., Kucukali T. Medical treatment of vulvar squamous cell hyperplasia. Int J Gynaecol Obstet 2006; 95: 278–83
- Jonathan S., Berek: Berek and Novak's gynecology. 14th edition. Lippincott Williams & Wilkins, 2007. p. 496
- Grassberger M., Steinhoff M., Schneider D., Luger T. A. Pimecrolimus – an anti‐inflammatory drug targeting the skin. Exp Dermatol 2004; 13: 721–30
- Graham‐Brown R. A. C., Grassberger M. Pimecrolimus: A review of pre‐clinical and clinical data. Int J Clin Pract 2003; 57: 319–27
- Hoetzenecker W., Meingassner J. G., Ecker R., Stingl G., Stuetz A., Elbe‐Bürger A. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J Invest Dermatol 2004; 122: 673–84
- Kalthoff F. S., Chung J., Musser P., Stuetz A. Pimecrolimus does not affect the differentiation, maturation and function of human monocyte‐derived dendritic cells, in contrast to corticosteroids. Clin Exp Immunol 2003; 133: 350–9
- Panhans‐Gross A., Novak N., Kraft S., Bieber T. Human epidermal Langherans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol 2001; 107: 345–52
- Gupta A. K., Chow M. Pimecrolimus: A review. J Eur Acad Dermatol Venereol 2003; 17: 493–503
- Goldstein A. T., Marinoff S. C., Christopher K. Pimecrolimus fort the treatment of vulvar lichen sclerosis: A report of 4 cases. J Reprod Med 2004; 49: 778–80
- Nghiem P., Pearson G., Langley R. G. Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 2002; 46: 228–41
- Billich A., Aschauer H., Aszódi A., Stuetz A. Percutaneous absorbtion of drugs used in atopic eczema: Pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm 2004; 269: 29–35
- Boms S., Gambichler T., Freitag M., Altmeyer P., Kreuter A. Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood. BMC Dermatol 2004; 4: 14
- Goldstein A. T., Marinoff S. C., Christopher K. Pimecrolimus for the treatment of vulvar lichen sclerosus: A report of 4 cases. J Reprod Med 2004; 49: 778–80